CMS initiated public reporting of post-TJR readmissions and complications in 2014. To anticipate and monitor quality, arthroplasty surgeons need timely and risk-adjusted data to monitor outcomes to meet or exceed national goals. FORCE-TJR comparative reports support quality monitoring efforts. Second, CMS issued a draft report proposing PRO collection and analysis following TJR. Two FORCE surgeons contributed to this planning effort, and participants in the FORCE network already meet the future expectations. Finally, FORCE-TJR proposed collaborations with both CMS and private insurers to clarify the role of PROs in defining TJR need and outcomes. These future studies will guide efficient and effective patient selection and TJR care.